Improving the problems of existing antimicrobial substances & opening the possibility of overcoming acne resistance with ‘antibacterial peptide C4’

Celltem has recently made waves in the skincare and scientific communities with their development of a ground-breaking paradigm of antimicrobial peptide C4. It has been shown to dramatically reduce the side effects of current antimicrobial-based acne treatments as well as address the issue of existing antibiotic resistance.

The research and development team at Celltem noted that there were rumblings of discontent with current antimicrobial-based acne treatments. These treatments have side effects that range from redness, skin irritation, contact dermatitis, antibiotic resistance, and even fever in some cases.

Celltem has addressed these issues through research, development, and the extraction of antimicrobial peptide C4 from milk protein – garnering praise from the scientific community for its potency and efficacy.

How Does Antimicrobial Peptide C4 Target Acne-Related Ailments?

Antimicrobial Peptide C4 attacks five foundational pathogenic bacteria on the epidermis. It has been shown to have a remarkably potency and efficiency in targeting these pathogenic bacteria which includes Cutibacterium acnes (C. acnes). One of the claimed mechanisms of Antimicrobial Peptide C4 is its ability to target membranes that protect detrimental bacteria, thus showcasing an inhibitory effect.

Celltem Addresses the Current Issues Stemming from Current Antimicrobial Treatments

One of the primary concerns associated with current iterations of antibiotics and microbial ingredients is the fact that they systemically attack both harmful and beneficial bacteria on the epidermis. The main detraction of this is that defensive bacteria would usually serve as a barrier/protector from antimicrobial treatments.

If all good bacteria are attacked/destroyed with debilitating bacteria, then the user is more susceptible to skin irritations and side effects (mentioned above).

Celltem’s Antimicrobial Peptide C4 addresses this issue by finessing the substance to not only attack bad bacteria but actively protect good bacteria present on the skin. As bacteria is targeted with more precision, the result for users is a lessened risk of negative side effects that correlate from the loss of beneficial bacteria.

Celltem’s Antimicrobial Peptide C4

How Percent Science Has Commercialized the Concept

Bio-cosmetic player Percent Science has cornered the skin care market with a product containing Antimicrobial Peptide C4 by utilizing biotechnology and embracing cytotoxicity, stabilization, and in-vitro efficacy tests.

Achieving commercial stability has proven to be the biggest hurdle as antimicrobial peptide C4 has such a high efficacy rate as a microbial substance.

Sponsored Article
Sponsored Article
Disclaimer: This article is a private opinion, provided and sponsored by a third party. We don't make any representation as to the accuracy or completeness of any information included in this article, read more here.
Share this